Convalescent plasma is a leading treatment for coronavirus disease 2019 (COVID-19), but
there is a paucity of data identifying its therapeutic efficacy. Among 126 potential …

Accurate serological assays to detect antibodies to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are needed to characterize the epidemiology of SARS-CoV-2 …

Background Convalescent plasma therapy is a leading treatment for conferring temporary
immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis. …

Background The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma (CCP)
is primarily ascribed as a source of neutralizing anti-severe acute respiratory syndrome …

Oral fluid (hereafter saliva) offers a non-invasive sampling method for detection of SARS-CoV-2
antibodies. However, data comparing performance of salivary tests against commercially…

Background and Objectives ABO blood group may affect risk of SARS‐CoV‐2 infection and/or
severity of COVID‐19. We sought to determine whether IgG, IgA and neutralizing antibody …

Purpose: To prospectively compare diagnostic performance of conventional Doppler
ultrasonography (US) and microbubble contrast material–enhanced US for assessment of vascular …

Antibiotic-associated diarrhoea (AAD) is a common cause of morbidity and mortality. Older
individuals in long-term care facilities are particularly vulnerable due to multisystem illnesses …

Background Transfusion-transmitted infections (TTIs) are a global health challenge. One
new approach to reduce TTIs is the use of pathogen reduction technology (PRT). In vitro, …

Background The true burden of COVID‐19 in low‐ and middle‐income countries remains
poorly characterized, especially in Africa. Even prior to the availability of SARS‐CoV‐2 …